학술논문
Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration
Document Type
Article
Author
Source
In Clinical Lymphoma Myeloma and Leukemia February 2014 14(1):73-79
Subject
Language
ISSN
2152-2650